NCT01866163View on ClinicalTrials.gov

LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 90100

DRUG

Vehicle

Trial Locations (1)

63117

Central Dermatology, St Louis

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT01866163 - LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter